Clinical Trials Directory

Trials / Completed

CompletedNCT00555685

Hypertonic Saline Solution in Heart Failure

Hypertonic Saline Solution in Decompensated Heart Failure

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
34 (actual)
Sponsor
University of Sao Paulo · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients with decompensated heart failure have high rates of mortality and morbidity despite recent improvements in diagnosis and treatment. Some aspects of their presentation such as renal failure, hyponatremia and congestive phenomena have received special attention, as they are associated with worse prognosis. The infusion of hypertonic saline solution has been tested in different conditions of cardiovascular collapse. Current evidence indicates that the infusion of hypertonic solution in heart failure patients can provide clinical and haemodynamic improvement. The investigators are testing the hypothesis that the infusion of hypertonic solution in association with diuretics may prevent the occurrence of renal dysfunction in patients with decompensated heart failure.

Conditions

Interventions

TypeNameDescription
DRUGNaCl 7,5% (Hypertonic Saline Solution)Patients in the intervention arm will receive 100ml of NaCl 7,5, twice daily during 3 days
DRUGNaCl 0,9%Patients in the placebo arm will receive 100ml of NaCl 0,9% twice daily during 3 days

Timeline

Start date
2008-02-01
Primary completion
2010-02-01
Completion
2010-12-01
First posted
2007-11-09
Last updated
2014-06-10

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00555685. Inclusion in this directory is not an endorsement.